Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2011-03-15
2011-03-15
Naff, David M (Department: 1657)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S422000, C424S443000, C424S486000, C424S093700, C435S135000, C435S174000, C435S180000, C435S182000, C435S395000
Reexamination Certificate
active
07906135
ABSTRACT:
Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided for use in numerous biomedical applications. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. PHAs are provided which are suitable for use in vivo applications such as in tissue coatings, stents, sutures, tubing, bone and other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses. Properties which are selected for include degradability, elasticity, inclusion of functional groups or derivatized groups, which can in turn be used to attach targeting agents, and bioadhesion.
REFERENCES:
patent: 4648978 (1987-03-01), Makinen et al.
patent: 4711241 (1987-12-01), Lehmann
patent: 4910145 (1990-03-01), Holmes et al.
patent: 5026381 (1991-06-01), Li
patent: 5245023 (1993-09-01), Peoples et al.
patent: 5250430 (1993-10-01), Peoples et al.
patent: 5334698 (1994-08-01), Witholt et al.
patent: 5480394 (1996-01-01), Ishikawa
patent: 5480794 (1996-01-01), Peoples et al.
patent: 5512669 (1996-04-01), Peoples et al.
patent: 5516565 (1996-05-01), Matsumoto
patent: 5534432 (1996-07-01), Peoples et al.
patent: 5563239 (1996-10-01), Hubbs et al.
patent: 5584885 (1996-12-01), Seckel
patent: 5723010 (1998-03-01), Yui et al.
patent: 5735863 (1998-04-01), Della Valle
patent: 6245537 (2001-06-01), Williams et al.
patent: 6555123 (2003-04-01), Williams et al.
patent: 6610764 (2003-08-01), Martin et al.
patent: 6623749 (2003-09-01), Williams et al.
patent: 7244442 (2007-07-01), Williams et al.
patent: 258 781 (1988-03-01), None
patent: 0 628 586 (1994-12-01), None
patent: 628 586 (1994-12-01), None
patent: 0 754 467 (1997-01-01), None
patent: 754 467 (1997-01-01), None
patent: 07 275 344 (1995-10-01), None
patent: WO 98/51812 (1988-11-01), None
patent: WO 96/00263 (1996-01-01), None
patent: WO 96/24682 (1996-08-01), None
patent: WO 97/07153 (1997-02-01), None
patent: WO 98/48028 (1998-10-01), None
patent: WO 99/32536 (1999-07-01), None
Clavijo-Alvarez, et al. “Comparison of biodegradable conduits within aged rat sciatic nerve defects,”Plast Reconstr Surg. 119(6):1839-51(2007).
Kishida, et al. “Formulation assisted biodegradeable polymer matrices”Chemical and Pharmaceutical Bulletin, JP Pharm Society of Japan. 37(7)1954-1956(1989).
Pouton, et al. “Biosynthetic polyhydroxyalkanoates and their potentials in drug delivery”Adv. Drug Deliv. Rev. 18(18):133-162.
Schlosshauer, “Synthetic nerve guide implants in humans: a comprehensive survey.”Neurosurgery59:740-748 (2006).
Agostini, et al., “Synthesis and Characterization of Poly-β-Hydroxybutyrate. I. Synthesis of Crystalline DL Poly-β-Hydroxybutyrate from DL-β-Butyrolactone,”Polym. Sci., Part A-1, 9:2775-87 (1971).
Akhtar, “Physiomechanical Properties of bacterial P(HB-HV) Polyesters and Their Uses in drug Delivery,” The British Library Document Supply Centre, UMI, (1990).
Anderson, et al., “Occurrence, Metabolism, metabolic Role, and Industrial Uses of bacterial Polyhydroxyalkanoates,”Microbiological Reviewspp. 450-472 (1990).
Berger, et al., “PHB recovery by hypochlorite digestion of non-PHB biomass”,Biotechnology Techniques, 3(4):227-232 (1989).
Byrom, “Miscellaneous Biomaterials,” in Biomaterials (D. Byrom, ed.) pp. 333-359 (MacMillan Publishers, London 1991).
Conti, B. et al., “Use of polylactic acid for the preparation of microparticulate drug delivery systems,”J. Microencapsulation9:153-166 (1992).
Cookson, “It grows on trees,”Financial Timesp. 6 (Aug. 12, 1992).
De Smet, et al., “Characterization of intracellular inclusions formed byPseudomonas oleovoransduring growth on octane,”J. Bacteriol. 154:870-78 (1983).
Dubois, et al., “Macromolecular Engineering of Polylactones and Polylactides. 12. Study of the Depolymerization Reactions of Poly(ε-caprolactone) with Functional Aluminum Alkooxide End Groups,”Macromolecules26:4407-12 (1993).
Gagnon, et al., “A thermoplastic elastomer produced by the bacteriumPseudomonas oleovarans,” Rubber World207:32-38 (1992).
Gagnon, et al., “Chemical modification of bacterial elastomers: 1. Peroxide crosslinking,”Polymer35:4358-67 (1994).
Gross, at al., “β-Monesubstituted-β-propiolactones Using Trialkylaluminum-Water Catalytic Systems and Polymer Characterization,”Macromolecules21:2657-68 (1988).
Hocking, “Biopolyesters” inChemistry and Technology of Biodegradable Polymers, (G.J.L. Griffin, ed.) pp. 48-96 (Chapman and Hall, London 1994).
Hocking, et al., R.H., “Syndiotactic poly[(R,S)-β-hydroxybutyrate] isolated from methyaluminum-catalyzed polymerization,”Polym. Bull. 30:163-70 (1993).
Holmes, P.A., “Biologically Produced (B)-3-hydroxyalkanoate Polymers and Copolymers,” in D.C. Bassett Ed., “Developments in Crystalline Polymers,” Elsevier, London, vol. 2, 1988, pp. 1-65.
Hori, et al., “Ring-Opening Copolymerization of Optically Active β-Butyrolactone with Several Lactones Catalyzed by Distannoxane Complexes: Synthesis of New Biodegradable Polyesters,”Macromolecules26:4388-90 (1993).
Hori, et al., “Ring-Opening Polymerization of optically Active β-Butyrolactone Using Distannoxane Catalysts: Synthesis of High Molecular Wright Poly(3-hydroxybutyrate),”Macromolecules26:5533-34 (1993).
Horsch, “Inheritance of Functional Foreign Genes in Plants”Science223:49-498 (1984).
Huijberts, et al., “Pseudomonas putida KT2442 cultivated on glucose accumulates poly(3-hydroxyalkanoates) consisting of saturated and unsaturated monomers”,Appl Environ Microbiol., 58(2):536-44 (1992).
Keeler, “Plastics Grown in Bacteria Inch Toward the Market,”R&D Magazinepp. 46-52 (1991).
Keeler, “Don't Let Food Go To Waste—Make Plastic Out of It,”R&D Magazinepp. 52-57 (1991).
Kemnitzer, J.E. et al., “Preparation of predominantly Syndiotactic Poly(β-hydroxybutyrate) by the Tributylin Methoxide Catalyzed Ring-Opening Polymerization of racemic β-Butyrolactone,”Macromolecules26:1221-29 (1993).
Koosha, “Preparation and characterization of biodegradable polymeric drug carriers,” Ph.D. Dissertation, 1989,Univ. Nottingham, UK.,Diss. Abstr. Int. B51:1206 (1990).
Lafferty, et al, “Microbial Production of Poly-b-hydroxybutyric acid,” H.J. Rehm and G. Reed, Eds., “Biotechnology”, Verlagsgesellschaft, Weinheim, vol. 66, 1988, pp. 135-176.
Le Borgne, at al,, “Stereoselective polymerization of β-bytyrolactone,”Polymer30:2312-19 (1989).
Lemoigne and Roukhelman, “Fermetation β-Hydroxybutyrique Caracterisation et Evolution Des Produits de Deshydration et de Polymerisation de L'acide β-Dehydroxybutyrique,”Annales des fermentations, 5:527-36 (1925).
Lloyd, et al. “Transformation ofArabidopsis thalaniawithAgrobacterium tumefaciens,” Science234:464-466 (1986).
Mathiowitz & Langer, “Polyanhydride microspheres as drug delivery systems,” M. Donbrow Ed., inMicrocapsule Nanopart. Med. Pharm.CRC, Boca Raton, Florida, 1992, Ch. 5, pp. 99-123.
Maysinger, “Microencapsulation and the Grafting Genetically Transformed Cells as Therapeutic Strategies to rescue Degenerating Neurons of the CNS,”Reviews in the Neurosciences
Gerngross Tillman
Horowitz Daniel M.
Martin David P.
Williams Simon F.
Metabolix Inc.
Naff David M
Pabst Patent Group LLP
LandOfFree
Medical device comprising polyhydroxyalkanoate having... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical device comprising polyhydroxyalkanoate having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical device comprising polyhydroxyalkanoate having... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742894